PDB34 A COST-MINIMIZATION ANALYSIS FOR TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETERMIR IN A BASAL SUPPORTED ORAL THERAPY IN CHINA
May 1, 2010, 00:00
10.1016/S1098-3015(10)72281-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)72281-6/fulltext
Title :
PDB34 A COST-MINIMIZATION ANALYSIS FOR TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETERMIR IN A BASAL SUPPORTED ORAL THERAPY IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72281-6&doi=10.1016/S1098-3015(10)72281-6
First page :
Section Title :
Open access? :
No
Section Order :
874